PharmiWeb.com - Global Pharma News & Resources
08-Jan-2019

Global Sarcoma Therapeutics Market 2019-2023 - Key Players are Bayer, Eisai, Eli Lilly, Johnson & Johnson and Novartis - ResearchAndMarkets.com

The "Global Sarcoma Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The sarcoma therapeutics market will register a CAGR of more than 8% by 2023.

The advent of regenerative medicine to drive growth in the market

One of the most advanced and extensively researched treatment methods is regenerative medicines, including gene therapy. In gene therapy, the mutated gene is taken from the patient and is modified genetically in laboratory and administered back into the patient.

Launch of novel drugs

The market is currently dominated by the sales of GLEEVEC for the treatment of sarcomas. The launch of novel drugs is expected to be one of the major growth drivers in the market.

High treatment costs

The cost of therapeutics is usually high as most of the drugs that are currently approved in the market are large molecules. These drugs are expensive due to the complex manufacturing process of biologicals and high R&D costs.

Key Players

  • Bayer
  • Eisai
  • Eli Lilly
  • Johnson & Johnson
  • Novartis

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Soft tissue sarcoma - Market size and forecast 2018-2023
  • Osteosarcoma - Market size and forecast 2018-2023
  • Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer
  • Eisai
  • Eli Lilly
  • Johnson & Johnson
  • Novartis

For more information about this report visit https://www.researchandmarkets.com/research/nw662h/global_sarcoma?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190108005823/en/

Editor Details

Last Updated: 08-Jan-2019